My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Barcelona, Spain: Radiotherapy after breast conserving surgery in conjunction with chemotherapy or tamoxifen to treat early breast cancer reduces the risk of the disease returning in the same breast in the…
Every day, one person in Switzerland is diagnosed with multiple sclerosis. MS is an autoimmune disease in which the body’s own immune system attacks the myelin sheath of the nerve…
Note: This presentation is titled “AWAreness during REsuscitation II: a multicenter study of consciousness and awareness in cardiac arrest,” and is scheduled to be presented during the resuscitation science symposium…
TUCSON, Arizona — People with post-traumatic stress disorder (PTSD) experienced better sleep, a reduction in the severity of PTSD symptoms and more effective treatments after exposure to blue light therapy,…
NEW ORLEANS — Wearing special green eyeglasses for several hours a day reduces pain-related anxiety and may help decrease the need for opioids to manage severe pain in fibromyalgia patients and…
CORVALLIS, Ore. – Cystic fibrosis patients who supplement their diet with vitamin C can also derive greater benefit from another antioxidant, vitamin E, resulting in a reduction in damaging inflammation,…
At the European Football Championship last summer, time suddenly stood still. The buzzing tension that filled the air disappeared in a matter of seconds when footballer Christian Eriksen suddenly collapsed,…
Personal protective equipment (PPE) was rarely out of the news throughout the peaks of the COVID-19 pandemic. However new research published in Anaesthesia (a journal of the Association of Anaesthetists) shows that…
(7 September 2022, Milan, Italy) Vitamin D levels affect overall survival for melanoma (skin cancer) patients, a new study presented at the 31st European Academy of Dermatology and Venereology (EADV) Congress has shown.1…
Patients diagnosed with cancer more than one year ago and those not receiving active treatment were no more vulnerable to worse COVID-19 outcomes than patients without cancer, according to a…
FRANKFURT. SARS-CoV-2, the coronavirus that causes COVID-19, needs its spike proteins to dock onto proteins (ACE receptors) on the surface of the host cells. Before this docking is possible, parts…
An updated estimate says it could be at least 210,000 patients a year, more than twice the number in a frequently quoted Institute of Medicine report By Marshall Allen and…
You must be logged in to post a comment.